Gilead Sciences Publishes 2023 ESG Impact Report

Gilead Science Supports Increasing Diversity in Clinical Trials: 2024 Toward Health Equity Oncology Grant Supports 36 Global Organizations

Gilead Named One of America’s Most JUST Companies by JUST Capital and CNBC

Gilead Named to Dow Jones Sustainability World Index for Third Consecutive Year